217 related articles for article (PubMed ID: 17628858)
21. CD8+ T-cell tolerance can be broken by an adenoviral vaccine while CD4+ T-cell tolerance is broken by additional co-administration of a Toll-like receptor ligand.
Salucci V; Mennuni C; Calvaruso F; Cerino R; Neuner P; Ciliberto G; La Monica N; Scarselli E
Scand J Immunol; 2006 Jan; 63(1):35-41. PubMed ID: 16398699
[TBL] [Abstract][Full Text] [Related]
22. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
[TBL] [Abstract][Full Text] [Related]
23. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
[TBL] [Abstract][Full Text] [Related]
24. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
[TBL] [Abstract][Full Text] [Related]
25. Vaccination with irradiated Listeria induces protective T cell immunity.
Datta SK; Okamoto S; Hayashi T; Shin SS; Mihajlov I; Fermin A; Guiney DG; Fierer J; Raz E
Immunity; 2006 Jul; 25(1):143-52. PubMed ID: 16860763
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
[TBL] [Abstract][Full Text] [Related]
28. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.
Winau F; Weber S; Sad S; de Diego J; Hoops SL; Breiden B; Sandhoff K; Brinkmann V; Kaufmann SH; Schaible UE
Immunity; 2006 Jan; 24(1):105-17. PubMed ID: 16413927
[TBL] [Abstract][Full Text] [Related]
29. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
[TBL] [Abstract][Full Text] [Related]
30. TLR gateways to CD1 function.
Moody DB
Nat Immunol; 2006 Aug; 7(8):811-7. PubMed ID: 16855607
[TBL] [Abstract][Full Text] [Related]
31. Toll-dependent selection of microbial antigens for presentation by dendritic cells.
Blander JM; Medzhitov R
Nature; 2006 Apr; 440(7085):808-12. PubMed ID: 16489357
[TBL] [Abstract][Full Text] [Related]
32. Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines.
Heit A; Schmitz F; O'Keeffe M; Staib C; Busch DH; Wagner H; Huster KM
J Immunol; 2005 Apr; 174(7):4373-80. PubMed ID: 15778402
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
[TBL] [Abstract][Full Text] [Related]
34. Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells.
Solbrig CM; Saucier-Sawyer JK; Cody V; Saltzman WM; Hanlon DJ
Mol Pharm; 2007; 4(1):47-57. PubMed ID: 17217312
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of protein-loaded hydrogel particles in an aqueous two-phase system for coincident antigen and CpG oligonucleotide delivery to antigen-presenting cells.
Jain S; Yap WT; Irvine DJ
Biomacromolecules; 2005; 6(5):2590-600. PubMed ID: 16153096
[TBL] [Abstract][Full Text] [Related]
36. Exogenous antigens internalized through transferrin receptors activate CD4+ T cells.
McCoy KL; Noone M; Inman JK; Stutzman R
J Immunol; 1993 Mar; 150(5):1691-704. PubMed ID: 8094728
[TBL] [Abstract][Full Text] [Related]
37. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.
Rosalia RA; Cruz LJ; van Duikeren S; Tromp AT; Silva AL; Jiskoot W; de Gruijl T; Löwik C; Oostendorp J; van der Burg SH; Ossendorp F
Biomaterials; 2015 Feb; 40():88-97. PubMed ID: 25465442
[TBL] [Abstract][Full Text] [Related]
38. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity.
Wilson NS; Behrens GM; Lundie RJ; Smith CM; Waithman J; Young L; Forehan SP; Mount A; Steptoe RJ; Shortman KD; de Koning-Ward TF; Belz GT; Carbone FR; Crabb BS; Heath WR; Villadangos JA
Nat Immunol; 2006 Feb; 7(2):165-72. PubMed ID: 16415871
[TBL] [Abstract][Full Text] [Related]
39. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
[TBL] [Abstract][Full Text] [Related]
40. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
